FDA Issues Response to Avedro's New Drug Application for Corneal Cross-linking

posted Mar 23, 2014, 3:35 PM by Jen Weigel
Well, a couple of things ...

One, I was surprised that the FDA stuck to their deadline of March 15 for issuing a ruling on the NDA for cross-linking.  When has the government ever been good about sticking to a deadline, especially lately?

Two, I knew it was too good to be true to hope that they'd rule in favor of approving the procedure.  Mind you, I don't think that I read anywhere that this response would include approval, especially since our study is still on-going, but I did have high hopes!

Looks like we are still in the compiling data stage in our study.  It's been pretty cool to see our patients progress and work directly with Avedro as they've implemented the study across the country. 

Check out the original press release from Avedro here.  - jw
Comments